PhenoVista Appoints Ellen Berg, PhD, an Expert in the Mechanisms of Drug and Disease Biology and Cell-Based Assays, to its Scientific Advisory Board

Dr. Berg is the Founder of Alto Predict and is an expert in human cell-based in vitro assays...
Read more

 

Scientist.com and PhenoVista Launch World’s First Digital Storefront Offering Research Services for the Biotech Industry

Complex phenotypic studies can be designed, purchased, and managed through the online shop...
Read more

 

PhenoVista Appoints Pharmaceutical Industry Veteran and Toxicology Expert Eckhard von Keutz, PhD to its Scientific Advisory Board

Phenovista, a life sciences services company developing and implementing multiplexed, high content imaging-based phenotypic assays...
Read more

 

Fuijifilm's Life Sciences Corporate Venture Capital Fund Invests in PhenoVista Biosciences 

Investment will accelerate development of new, high-content screening assays... 

Read more

 

Justin Mika Joins PhenoVista Biosciences' Board of Advisors

Mika will help guide PhenoVista's leadership in the company's new phase of growth... 

Read more

 

TumorGen and PhenoVista Capture the Seeds that Drive Cancer Metastasis 

TumorGen's microfluidic platform traps metastatic cancer cell clusters from lung cancer patients, creating new opportunities for anti-metastatic drug development... 

Read more